NCT06256783

A Clinical Study of Baozhu Keli in the Treatment of Ovarian Aging

The Efficacy and Safety of Chinese Herbal Compound Baozhu Keli in the Treatment of Ovarian Aging: A Multicenter and Prospective Study.

• Status: Unknown
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Tongji Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

Ovarian aging (OA) seriously affects the physical and mental health of women. Nowadays, Chinese herbs have huge appeal and potential in treating OA. We have created a new Chinese herbal combination Baozhu Keli, whereas its safety and efficacy still need to be validated. Hence, we will perform a population-based, multicenter study to confirm the safety and efficacy of Baozhu Keli in therapy of OA. We aim to provide a solid evidence for TCM in therapy of OA.

Conditions

• Ovarian Aging

Interventions

Type	Name	Description
DRUG	Baozhu Keli	Once enrolled, participants will be administrated Baozhu Keli

Timeline

• Start date: 2022-08-01
• Primary completion: 2024-01-01
• Completion: 2025-01-01
• First posted: 2024-02-13
• Last updated: 2024-02-13

Locations

1 site across 1 country: China